Ambu's stock hits lowest price in five years
An analyst from Carnegie says there are several factors explaining why the medtech firm’s share price has declined to a level not seen since 2017.
by marketwire, translated by daniel pedersen
Ambu has been facing headwinds on the stock exchange in recent days, and Head of Equity Research at Carnegie Investment Bank Niels Granholm-Leth has identified several potential factors as to why.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
